Peptide-binding G protein-coupled receptors: New opportunities for drug design

Current Medicinal Chemistry

Volumn 8, Issue 13, 2001, Pages 1605-1648

  Gurrath, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTYL 1 [4 (2 CARBOXYBENZAMIDO)BENZYL] 4 CHLORO 5 IMIDAZOLEACETIC ACID METHYL ESTER; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; 4 TERT BUTYL N [6 (2 HYDROXYETHOXY) 5 (3 METHOXYPHENOXY) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 4' (2 BUTYL 4 CHLORO 5 HYDROXYMETHYL 1H IMIDAZOL 1 YLMETHYL) 2 BIPHENYLCARBOXYLIC ACID; 5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; A 182026; A 216546; A 308165; ACETANILIDE; ANGIOTENSIN; ANGIOTENSIN II ANTAGONIST; ANTHRAQUINONE DERIVATIVE; ARYL SULFONAMIDE; ATRASENTAN; BIOGENIC AMINE; BOSENTAN; BRADYKININ; BUTENOLIDE; CANDESARTAN; COMPLEMENT COMPONENT C5A; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DP 145065; ENDOTHELIN RECEPTOR ANTAGONIST; ENRASENTAN; EPROSARTAN; G PROTEIN COUPLED RECEPTOR; GONADORELIN; INDAN DERIVATIVE; IRBESARTAN; IRL 2500; ISOXAOLYL SULFONAMIDE; L 749329; L 751281; L 754142; LOSARTAN; LOSARTAN POTASSIUM; MONOAMINE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NEUROKININ; NEUROPEPTIDE Y; PD 156252; PYRROLIDINE DERIVATIVE; RES 701 1; SITAXSENTAN; SOMATOSTATIN; SULFONAMIDE; TAK 044; TBC 2576; TELMISARTAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN;

ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL CHEMISTRY; COUGHING; DISEASE COURSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG DESIGN; DRUG MARKETING; DRUG POTENTIATION; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; HUMAN; MEDICAL RESEARCH; MEDICINE; MEMBRANE POTENTIAL; MODULATION; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; NONHUMAN; PRESCRIPTION; PROTEIN BINDING; PROTEIN FAMILY; RAT; REVIEW; SIGNAL TRANSDUCTION; TREATMENT PLANNING;

EID: 0035170022     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867013371798     Document Type: Article

References (296)

1. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostatis
2. Angiotensin Converting Enzyme Inhibitors: New Clinical Applications
3. The pharmacology and immunopharmacology of kinin receptors
4. Tachykinins in Health and Disease, Cairns, Australia
5. Tachykinins in Health and Disease, Cairnes, Australia